drugset / Trial / NCT04895215
AB-2004 in Treatment of Irritability Associated With Autism Spectrum Disorder (ASD)
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to establish the potential benefits, safety, and tolerability of AB-2004 in participants with irritability associated with autism spectrum disorder.
Timeline
- Start
- 2021-08-02
- Primary completion
- 2023-11-15
- Completion
- 2023-12-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AB-2004 | Unknown | — | — |